Arkolith/Insider Trading/OCUP/Form 4

Jhaveri Nirav S.

Chief Financial OfficerOcuphire Pharma, Inc. (OCUP) · full profile →Form 4 · filed Mar 25, 2024
Net Buying
Open-Market Buys
$21K
Open-Market Sells
$0
Net Open-Market Flow
$21K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 21, 2024Buy(P)10K$2.10$21K150K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-24-000997) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML